Summary: Since tens of millions of chemical compounds have been accumulated in public chemical databases, fast comprehensive computational methods to predict interactions between chemical compounds and proteins are needed for virtual screening of lead compounds. Previously, we proposed a novel method for predicting protein-chemical interactions using two-layer Support Vector Machine classifiers that require only readily available biochemical data, i.e. amino acid sequences of proteins and structure formulas of chemical compounds.
INTRODUCTION
Due to the limitations in experimental methods for determining interactions between proteins and chemical compounds, a comprehensive computational approach is useful in the early stages of the drug discovery process. Although 3D structure-based methods such as docking analysis (Morris et al., 1998) have been studied intensively in this field, they are still time-consuming and not really feasible for genome-wide application.
To address the problem, we developed a comprehensively applicable statistical prediction method for interactions between any protein and chemical compound, that requires only protein * To whom correspondence should be addressed. sequence data and chemical structure data and utilizes the statistical learning method of Support Vector Machines (SVM) (Nagamine and Sakakibara, 2007; Nagamine et al., 2009) . We have shown the usefulness of our approach in searching potential ligands binding to human androgen receptors from >19 million chemical compounds and verifying these predictions by in vitro binding (Nagamine et al., 2009) .
METHODS AND IMPLEMENTATION
We approach the problem as binary classification of protein-chemical pairs whose abstractive identities are represented numerically. An amino acid sequence of protein is converted to a multi-dimensional feature vector representing trimer frequencies, while a chemical compound is converted to a feature vector representing frequencies of substructure occurrences in the structural formula.
We obtained a 'positive' sample set, i.e. a set of protein-chemical pairs that have been proven to interact with each other via biological assays, from the DrugBank database (Wishart et al., 2008) . In addition, SVM-based classifiers require a 'negative' sample set, containing protein-chemical pairs that do not interact with each other, which can be extracted randomly from the complement set of the positive sample set. Using the resultant positive and negative protein-chemical pair sets, we trained two-layer SVMs. First, we trained each of the multiple first-layer SVMs with small sample sets designed using different criteria. Next, using another larger sample set, we trained a second-layer SVM whose input is a set of probabilities output from the first-layer SVMs.
The prediction performances were evaluated by 10-fold cross-validation using the DrugBank database. Sensitivity, specificity, precision and accuracy values obtained are 0.954, 0.999, 0.984 and 0.997 respectively. Details of the algorithms and their prediction accuracy are given in Nagamine and Sakakibara (2007) and Nagamine et al. (2009) .
The prediction method has been implemented as the web-based software system COPICAT (COmprehensive Predictor of Interactions between Chemical compounds And Target proteins), available as the COPICAT web service. The core SVM modules of COPICAT use LIBSVM (Chang and Lin, 2011) with the rest of the system written mainly in Perl and C++. The web interface is built using Java Servlets, Apache Tomcat and MySQL. COPICAT integrates SVM-based prediction programs and associated large databases of proteins and chemical compounds.
COPICAT WEB SERVER AND FEATURES
The COPICAT web service offers easy use of the programs without having to download the code, store huge datasets or execute the programs on computationally intensive CPUs with large memories. Sakakibara et al. Training job: when a user uploads his own training data, an SVM trained with the user data is added to the pre-defined first-layer SVMs and then the second-layer SVM is re-trained using the augmented first-layer outputs.
(1) Sample data: the default positive samples were obtained from DrugBank. In addition, users can upload their own positive samples.
(2) First-layer model addition: users can choose to add pre-trained models to the first layer in three ways: (i) the user's own previously trained model. (ii) the system-side specialized models: 'Nuclear Receptor', 'Ion Channel', 'GPCR', and 'Enzyme'. (iii) other user trained models via the model circulation function.
Circulation of user-trained models:
COPICAT web service provides a function to circulate a user-trained model to other users wishing to combine the model with their own two-layer model. In this function, each user-trained model is assigned a model ID. Users, who are allowed to access the model, can reload the model through the ID certification process. Job example: a prediction job with 'dopamine receptor' (UniProt ID: P21728) submitted against 'DrugBank Approved Structures' returns the prediction result containing 22 candidate compounds such as CID:5440 (Thiethylperazine, a dopamine antagonist), CID:28864 (Lisuride) and CID:681 (Dopamine) each of which is linked to the PubChem database, as shown in Figure 1 . Prediction accuracy: we tested the accuracy of prediction jobs against databases. In prediction jobs against 'DrugBank Approved Drug Targets' with a query of every Drugbank approved structure, 99.9% of the known true target proteins were listed as the first rank (highest probability) except multiple targets.
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